ALT flares were linked to HBsAg reduction, seroclearance and seroconversion: interim results from a phase IIb study in chronic hepatitis B patients with 24-week treatment of subcutaneous PD-L1 Ab ASC22 (Envafolimab) plus nucleos (t)ide analogsGuiqiang Wang, Jinzi J. Wu, Yimin Cui et al.|Journal of Hepatology|2022Cited by 20
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trialMingyuan Zhang, Junqi Niu, Yanhang Gao et al.|Journal of Infection|2025Cited by 6
Infliximab reduces colectomy in patients with moderate-to-severe ulcerative colitis: colectomy analysis from ACT 1 and ACT 2Sandborn, J.F. Colombel, Paul Rutgeerts et al.|Inflammatory Bowel Diseases|2008Cited by 5
The Impact of Active Screening and Management on COVID-19 in Plateau Region of Sichuan, ChinaJiajie Lu, Guoping Li, Lang Bai et al.|Frontiers in Medicine|2022Cited by 3